On Friday, Shares of WMIH Corp.(NASDAQ:WMIH), subtract -9.09% and closed at $1.50 in the last trading session. The last trading range of the stock ranges between $1.40 and $1.65. The company’s Market capitalization is $309.57 million with the total Outstanding Shares of 206.38 million. WMIH Corp., through its partner, WM Mortgage Reinsurance Company, Inc., engages in reinsurance business with respect to mortgage insurance in runoff mode. The company was formerly known as WMI Holdings Corp. and changed its name to WMIH Corp. in May 2015.
Technical Analysis: During the 52-week trading session the minimum price at which share price traded, registered at $1.40 and reached to max level of $2.94. The EPS of company is strolling at 0.52.
Shares of Johnson & Johnson (NYSE:JNJ), dropped -0.90% and closed at $118.47 in the last trading session. The last trading range of the stock ranges between $118.13 and $119.49. The company’s Market capitalization is $319.42 Billion with the total Outstanding Shares of 2.72 billion. Johnson & Johnson, together with its auxiliaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates through three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSONS brand name; oral care products under the LISTERINE brand name; skin care products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSONS Adult, LE PETITE MARSEILLAIS, LUBRIDERM, NEUTROGENA, and RoC brand names; womens health products, such as sanitary pads under the STAYFREE and CAREFREE, and o.b. tampon brand names; wound care products, counting adhesive bandages under the BAND-AID brand name and first aid products under the NEOSPORIN brand name. This segment also provides over-the-counter medicines, counting acetaminophen products under the TYLENOL brand name; cold, flu, and allergy products under the SUDAFED brand name; allergy products under the BENADRYL and ZYRTEC brand names; ibuprofen products under the MOTRIN IB brand name; and heartburn products under the PEPCID brand name. The Pharmaceutical segment provides various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases.
Technical Analysis: During the 52-week trading session the minimum price at which share price traded, registered at $94.28 and reached to max level of $126.07. The EPS of company is strolling at 5.71.